WeVote
Log In

Bill

Bill

HB 1141

provide an exception for employers to acquire and distribute opioid antagonists that are available over the counter.

2025 Regular Session Introduced by Aaron Aylward and 35 co-sponsors

South Dakota allows employers to legally purchase and distribute over-the-counter opioid antagonists in workplaces to increase emergency overdose response capacity.

Signed by the Governor on 2025-03-13 H.J. 542
#healthcare #publichealthandsafety
0
WeVote Research Nonpartisan
Bill Summary · HB 1141

Legislative bill overview

HB 1141 allows South Dakota employers to purchase and distribute over-the-counter opioid antagonists (such as naloxone/Narcan) to their employees and workplaces without legal liability concerns. The bill creates a legal exemption enabling employers to stock these life-saving medications as part of workplace safety measures.

Why is this important

Opioid overdoses remain a significant public health threat, and immediate access to antagonists can reverse overdoses and save lives. By removing legal barriers for employers to provide these medications, the bill potentially increases naloxone availability in workplaces and reduces barriers to emergency response during overdose events.

Potential points of contention

  • Cost allocation: Unclear whether employers bear full costs or if there are state subsidies, raising questions about which businesses can realistically participate
  • Liability protections scope: While the bill permits distribution, details on immunity from misuse or improper administration may be ambiguous
  • Training requirements: No mention of mandatory training for employees on proper naloxone administration, which could affect effectiveness
  • Workplace culture concerns: Some employers may resist stocking naloxone due to stigma or concerns about acknowledging substance use issues among staff

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.